{"id":967366,"date":"2026-05-27T08:07:22","date_gmt":"2026-05-27T12:07:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/"},"modified":"2026-05-27T08:07:22","modified_gmt":"2026-05-27T12:07:22","slug":"annexon-to-participate-in-upcoming-june-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/","title":{"rendered":"Annexon to Participate in Upcoming June Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BRISBANE, Calif., May  27, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QSIXGrJbOI0lyikBTqWQ_ZY3DNd31fXCxC-uMxfa4hJoVBTmqq4UNbPF2hMCrnVE0m_4gWhn-sD5tJ3HHADz1S4PAsB9d-0GAL39oDeqFhbbpzzMjMJZkTjacF1FZrNHbnqGs2WEg6xsF49hc7FFlubXWayBntGQy-B_QXZSryEWVMusDFsFz0BeTD0CPfTY8RsD1Iqajqmnba07Y2A4MzczxQAuK3rPJwgEAx1dd6k=\" rel=\"nofollow\" target=\"_blank\">Annexon, Inc.<\/a>\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and,\n<\/li>\n<li style=\"margin-bottom:8pt\">Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET in Miami Beach, FL.\n<\/li>\n<\/ul>\n<p>Live webcasts of the presentations can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=43gkU6vXeuLHpanVoY4AJ1riH-YKNbpXNZCfsdzFK2sji7rmDHh4slJm7iTXPHxaQaM90vjGG1Y1hyWFG-1lhghO4nI9i9ZomaG-qD10VTORtTfb_6RiUkaYH7wGgMA0wKhNAu7W6eZCod8zBQ1980vgsFSdcy6HEV3laUwmGUCBPaR1dNN4VAIBljkVKyIZfZZsGyBn883YuvVIe_EnoTnhT1qfZDcdBDPCKh_DJfI=\" rel=\"nofollow\" target=\"_blank\">annexonbio.com<\/a>. Replays of the webcasts will be archived on the Annexon website for 30 days following the presentations.<\/p>\n<p>\n        <strong>About Annexon<br \/><\/strong>Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million people worldwide living with serious neuroinflammatory diseases. Our founding scientific approach focuses on C1q, the initiating molecule of a potent inflammatory pathway that when misdirected can lead to tissue damage and loss of function in a host of diseases. Our targeted therapies are designed to stop classical complement-driven neuroinflammation at its source to provide meaningful functional benefit and alter the course of disease. Annexon\u2019s mission is to deliver game-changing therapies to patients so that they can live their best lives. To learn more visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=43gkU6vXeuLHpanVoY4AJwQAtyOOSCpLx4XdS9W4Flt2b54zfAPq9wMDghZrFzSIp04YeLZA9sUfq8Aytp-t32v9hsTBQnqbiq7Slql2qLOh9awtTMCpP_H3VJ1LzL6bJPmMSD3sKTzPzGxTKoicKb5zRKXTT_EY_fNuLLuJ9a_16wc9HYP_Hc55N26onjWSqHBA4UH1cH0rOsfizrkyAqFhL68JXoT8JkpAWz_s6y0=\" rel=\"nofollow\" target=\"_blank\">annexonbio.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uS41lbLuwXtE2xpFrR3oyiiOFI6ZitMnmIJPEZHKUVnYU4xP641H00E2fZ6ajgTng3Si74HVhtrl8sQ785gqCFOSrpSUJZpaUPDjUQOr7HqgitneznGQLDNIwYvsfwLowJpmeyRTzSzhIHj0AlPqEkITnN6RmFHAI4a0pQWobcKxOfwva6CiToCuBImeKNwiFf_z_0oEMezl48SSWt7tnmGelgsjjbK01m4dnALVcWbx_EjYetuy1aJG2LmOn5G2l2ClLHGk5qPz3TfSZwn0NATODaSfxdlmmasn5qkfe-ZaErDGCodiVo3lEJMPIcJgXiBTUym_YnFYkknMXi-lm59iQC8Sen4HiGtHE3sCb5blckiH1Rp4E_HFAZcbY_-eNZW2ED_OgkeA4BmgyfDhf24C8sutcYf2PwNBk9KJSCdWOGkhbiuNszAlafDTq6gx4R5cZWylCvHvKdXN8LMV8K_Lfol3Cl9yqVH0c3lIFw32OtJEyi0-WY-G9fiyefgOhAqR5P7Ty9YWweSZOm354MSJYA35cMy79W7UkYmtIkKidV5cj8c34sJaYCRlEhdf\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Beth Keshishian<br \/>917-912-7195<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1sCR1IeWxkwPpDpuNVEK6IMg99MDWvJszxmNu7Rs9AKUzV15S7CzbPSvwn8MmnWkCnQbFzVCU2PfxMN-_7DOEB6fKJn4wOpbP5-bMjHwBxC4tkC3SjQIOTP2MykvH-mmoPkwnFQLBLWWqX1FEAWPoYdlPOlKdKMSVsOzlYzCYKHZlnyA0awl81LKz8mQqpwbS3k7eApUuWiLAIJI5oVzBXZgVk2F3cVOih5VwGapEKczFMarj9RzimLvHVFtFz-ipIe5Bp_E1N_KJTaZa2DWZBGUVUbABly0JJRUCzPF4d_5ubsup0b6T3doKl6_Gd0mVRDv7MApzadaGfBUgGXK3_ux9GQRlnCcyc6m5V8O89YwbBjmXJBirLhAaUozNuTvVPnnrp-M6ZncWpcipUcUjKEvMRy_amoQjutNKwA7SrOSchjC6qjuAa7rXY4bxUSyTj9cjaFkCgIja0QKEU3_HxIC6rbJSAID4Q8zL8IMD-5pCwcRRnx6dkdxfdDA7Errui4B3uUOZz-fy-VWBOmfiHwMFWIk-4IDROLm3m_mE9hV4_1hAo6y1QdGb8lV7R-Aaf49idx5goYpQrlXRaiHgjuWVuRZEe9MKJtv1yiFdkV5H4X-joDyxKDAmuwPF6xwo7-gmhRqAQTwyGCaCGsKBcEHuvky43wEHUn3Z9OMBLsj4D1eJ_M2cwHdJCA6vqpBFse3kx8IkvjW1WfF-ZBk2XjXbygPhGOMISFptINtPFa6Je_A4txYCdservVLIJiHc4R7Gs3cRANxD-bX_XXB7N-S0Xt8_dv4ywcfeGfRSxhwE_XVG_wpPkyFmm_NTXuIrAjYxpiIzJJ8KcdHDs0xXA==\" rel=\"nofollow\" target=\"_blank\">beth@bethkeshishian.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzQyOGFiYTItYWE2Yy00NDAwLTkxMzMtYTJlMDQ2OWJjNDVkLTEyMDE2NDUtMjAyNi0wNS0yNy1lbg==\/tiny\/Annexon-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences: Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET in Miami Beach, FL. Live webcasts of the presentations can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at annexonbio.com. Replays of the webcasts will be archived &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annexon to Participate in Upcoming June Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967366","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences: Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET in Miami Beach, FL. Live webcasts of the presentations can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at annexonbio.com. Replays of the webcasts will be archived &hellip; Continue reading &quot;Annexon to Participate in Upcoming June Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T12:07:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annexon to Participate in Upcoming June Investor Conferences\",\"datePublished\":\"2026-05-27T12:07:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/\",\"name\":\"Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\",\"datePublished\":\"2026-05-27T12:07:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-june-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annexon to Participate in Upcoming June Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk","og_description":"BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences: Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET in Miami Beach, FL. Live webcasts of the presentations can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at annexonbio.com. Replays of the webcasts will be archived &hellip; Continue reading \"Annexon to Participate in Upcoming June Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-27T12:07:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annexon to Participate in Upcoming June Investor Conferences","datePublished":"2026-05-27T12:07:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/","name":"Annexon to Participate in Upcoming June Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=","datePublished":"2026-05-27T12:07:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjc0NyM3NjIxODg4IzIxOTAwOTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-june-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annexon to Participate in Upcoming June Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967366"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967366\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}